Nautilus Biotechnology shares owned by Charles Schwab Investment Management
Quarter-by-quarter ownership of Nautilus Biotechnology (NAUT) shares owned by Charles Schwab Investment Management
from 13F filings
Historical chart of Charles Schwab Investment Management investment in Nautilus Biotechnology
Tip: Access up to 7 years of quarterly data
All positions including Nautilus Biotechnology held by Charles Schwab Investment Management consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Nautilus Biotechnology by Charles Schwab Investment Management
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-09-30 | $392k | 138k | 2.85 |
2024-06-30 | $322k | 138k | 2.34 |
2024-03-31 | $401k | 136k | 2.94 |
2023-12-31 | $408k | 136k | 2.99 |
2023-09-30 | $460k | 146k | 3.16 |
2023-06-30 | $533k | 138k | 3.87 |
2023-03-31 | $365k | 132k | 2.77 |
2022-12-31 | $229k | 127k | 1.80 |
2022-09-30 | $270k | 127k | 2.13 |
2022-06-30 | $342k | 127k | 2.69 |
2022-03-31 | $97k | 22k | 4.36 |
2021-12-31 | $116k | 22k | 5.21 |
2021-09-30 | $137k | 22k | 6.16 |
More positions owned by Charles Schwab Investment Management
Home Depot (HD)
View all positions for Charles Schwab Investment Management